From scientific research to healthcare markets

Byrski, Dennis (2021): From scientific research to healthcare markets: empirical essays on the economics of pharmaceutical innovation. Dissertation, LMU München: Faculty of Economics

Abstract

This dissertation offers new insights into the determinants of biomedical science and pharmaceutical innovation, each in a self-contained chapter. The first chapter investigates the functioning of research tool markets, which are important input factors into science. Specifically, it observes why short-term distortions to supply have enduring effects on tool adoption and, thus, the direction of scientific research. The second chapter examines whether pharmaceutical companies adjust their follow-on innovation activities when patentability standards increase. To this end, it analyses changes in the innovation incentives caused by a drug’s marketing authorization. The third chapter explores the relationship between downstream shifts in demand and upstream research. It studies whether a policy-induced increase in market size affects scientific publishing by universities and corporations. In summary, evidence from these micro-economic analyses may contribute to designing effective and efficient public policies that help stimulate R&D activities, foster the development of new pharmaceutical treatments, and eventually improve public health.

• Item Type: Theses (Dissertation, LMU Munich)
• Keywords: Economics of Innovation, Pharmaceutical Innovation, Biomedical Science, Research Tools, Patents, Patentability Standards, Drug Development, Medicare Part D
• Subjects: 300 Social sciences; 300 Social sciences > 330 Economics
• Faculties: Faculty of Economics
• Language: English
• Date of oral examination: 1. July 2021
• 1. Referee: Harhoff, Dietmar
• Signature of the printed copy: 0001/UMC 28312